AUTHOR: Danylo Zorin, MD
First-degree atrioventricular (AV) block is defined as a PR interval exceeding 200 msec with preserved 1:1 AV conduction relationship. AV block is actually a misnomer because every atrial impulse is conducted to ventricles, and some refer to this finding as first-degree AV delay.1,2
Atrioventricular conduction delay
|
Based on studies conducted in healthy volunteers, the incidence varies between 5 and 10 in 1000.
Overall prevalence between 1% and 2% has been reported. It increases with age from ∼1% in young (20- to 30-yr-old) adults to ∼3% to 4% by age 60. In a cohort over age 60, prevalence is ∼6%.3
Age (more common with advanced age), male sex (men on average have longer PR intervals), race (African Americans tend to have longer PR intervals), family history, and comorbid conditions (e.g., hypertension, diabetes) are major risk factors.
Genome-wide association studies identified genes (e.g., SCN5A and more recently SCN10A, encoding voltage-gated sodium channel) that can determine PR interval duration.4
Causes of AV block are numerous. They can be broadly divided into congenital and acquired. Acquired causes can in turn be broken down into infectious, inflammatory, degenerative, ischemic, vagotonic, metabolic, and iatrogenic. Congenital causes include conditions where a heart block is a part of a syndrome (such as myotonic dystrophy type 1, Emery-Dreifuss, limb-girdle type 1B) or a primary abnormality (as in familial Lev-Lenègre disease due to mutation of the SCN5A gene). A number of infections (Lyme disease, Chagas disease, toxoplasmosis), metabolic disorders (hyperkalemia, hypothyroidism), inflammatory conditions (systemic lupus erythematosus, rheumatoid arthritis, sarcoidosis), therapeutic interventions (beta-blockers, nondihydropyridine calcium channel blockers, valve surgeries, digoxin, etc.), toxins (CO, cyanide, mercury), degenerative processes (senile idiopathic fibrosis of the conduction system, aortic valve calcification), ischemia (acute myocardial infarction, chronic stable coronary artery disease), and increased vagal tone (in athletes or patients with sleep apnea) can be responsible for acquired AV block.1
Diagnosis of first-degree AV block is typically straightforward (see Definition) and made on a 12-lead electrocardiogram (ECG) or rhythm strip (Fig. E1). In rare cases of extreme AV delay, the P wave may be buried in preceding T wave or QRS complex, causing apparent AV dissociation.
The goal of workup is to establish the level of AV delay, its etiology, and its relationship to symptoms (if present). Workup is also indicated in asymptomatic patients who are at risk for progression to higher degrees of AV block (e.g., when certain hereditary conduction system disorders are suspected). It includes full history, physical examination, laboratory tests, and imaging studies.1,5
Selection of a particular test(s) is dictated by preliminary diagnosis(es), considered most likely based on the history and physical findings. Examples include thyroid function studies, basic metabolic panel, Lyme serology, endocardial biopsy, and genetic testing.
Treatment (Fig. E2) is indicated in patients with symptoms that correlate with the first-degree AV block or in patients without symptoms, but who are at risk for progression to higher degrees of AV block. The management of first-degree AV block is summarized in Table E1.
AVR, Aortic Valve Replacement; MI, Myocardial Infarction; PM, Pacemaker.
From Olshansky B et al: Arrhythmia essentials, ed 2, Philadelphia, 2017, Elsevier.
TABLE E1 First-Degree Atrioventricular Block Management
AV, Atrioventricular; AVB, atrioventricular block; AVN, atrioventricular node; DDD, dual-chamber; MI, myocardial infarction; TEE, transesophageal echocardiography.
From Olshansky B et al: Arrhythmia essentials, ed 2, Philadelphia, 2017, Elsevier.
In asymptomatic patients without high risk of progression to advanced AV block, treatment includes observation, reassurance, and education. Cardiac pacing is a nonpharmacologic treatment modality for appropriately selected patients (see below).
Patients with symptoms due to reversible causes of AV conduction delay should receive appropriate treatment (e.g., correction of electrolyte abnormalities, antimicrobial therapy of infections associated with AV block, withdrawal of offending medications) of underlying conditions responsible for AV block.1,5
Permanent cardiac pacing may be indicated in patients with symptoms that correlate with the first-degree AV block and persist after correction of reversible causes (class IIA). Patients without symptoms but at risk for progression to higher degrees of AV block also benefit from permanent cardiac pacing (Lamin A/C mutations with PR >240 msec and left bundle branch block class IIA), certain neurodegenerative disorders (including myotonic dystrophy type 1) with PR >240 msec and QRS >120 msec, or fascicular block (class IIB).1
AV conduction delay has been shown to be associated with increased risk of all-cause mortality, heart failure, and atrial fibrillation.2